These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 2676263

  • 1. Lipid lowering drugs in atherosclerosis--the HMG-CoA reductase inhibitors.
    Mantell G.
    Clin Exp Hypertens A; 1989; 11(5-6):927-41. PubMed ID: 2676263
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I, Spinler SA, Johnson NE.
    Ann Pharmacother; 1995 May; 29(7-8):743-59. PubMed ID: 8520093
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.
    Plosker GL, McTavish D.
    Drugs; 1995 Aug; 50(2):334-63. PubMed ID: 8521762
    [Abstract] [Full Text] [Related]

  • 6. Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.
    Illingworth DR, Bacon S.
    Am J Cardiol; 1987 Oct 30; 60(12):33G-42G. PubMed ID: 3314447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR, Tobert JA.
    Clin Ther; 1994 Oct 30; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [Abstract] [Full Text] [Related]

  • 10. Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal.
    Pedersen TR, Tobert JA.
    Drug Saf; 1996 Jan 30; 14(1):11-24. PubMed ID: 8713485
    [Abstract] [Full Text] [Related]

  • 11. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM, Thompson GR.
    Q J Med; 1990 Feb 30; 74(274):165-75. PubMed ID: 2111917
    [Abstract] [Full Text] [Related]

  • 12. Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study.
    Probstfield JL, Margitic SE, Byington RP, Espeland MA, Furberg CD.
    Am J Cardiol; 1995 Sep 28; 76(9):47C-53C. PubMed ID: 7572686
    [Abstract] [Full Text] [Related]

  • 13. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W, Wieland H.
    Herz; 2000 Mar 28; 25(2):117-25. PubMed ID: 10829251
    [Abstract] [Full Text] [Related]

  • 14. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
    Amin D, Gustafson SK, Weinacht JM, Cornell SA, Neuenschwander K, Kosmider B, Scotese AC, Regan JR, Perrone MH.
    Pharmacology; 1993 Mar 28; 46(1):13-22. PubMed ID: 8434028
    [Abstract] [Full Text] [Related]

  • 15. HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.
    Lintott CJ, Scott RS.
    Drugs Aging; 1992 Mar 28; 2(6):518-29. PubMed ID: 1493355
    [Abstract] [Full Text] [Related]

  • 16. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agents.
    Gordon DJ, Rifkind BM.
    Ann Intern Med; 1987 Nov 28; 107(5):759-61. PubMed ID: 3662286
    [No Abstract] [Full Text] [Related]

  • 17. Peripheral neuropathy and lipid-lowering therapy.
    Ziajka PE, Wehmeier T.
    South Med J; 1998 Jul 28; 91(7):667-8. PubMed ID: 9671841
    [Abstract] [Full Text] [Related]

  • 18. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
    Bach LA, Cooper ME, O'Brien RC, Jerums G.
    J Am Geriatr Soc; 1990 Jan 28; 38(1):10-4. PubMed ID: 2404052
    [Abstract] [Full Text] [Related]

  • 19. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
    Lintott CJ, Scott RS, Sutherland WH, Bremer J.
    Aust N Z J Med; 1993 Aug 28; 23(4):381-6. PubMed ID: 8240151
    [Abstract] [Full Text] [Related]

  • 20. Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders.
    Murdock DK, Murdock AK, Murdock RW, Olson KJ, Frane AM, Kersten ME, Joyce DM, Gantner SE.
    Am Heart J; 1999 Jul 28; 138(1 Pt 1):151-5. PubMed ID: 10385779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.